References
[1]. Ahmed, W., Qureshi, H., Arif, A., & Alam, S. E. (2010).
“Changing trend of viral hepatitis—A twenty one year report
from Pakistan Medical Research Council Research Centre,
Jinnah Postgraduate Medical Centre, Karachi". JPMA. The
Journal of the Pakistan Medical Association, Vol.60(2),
pp.86-89.
[2]. Alavian, S. M., Tabatabaei, S. V., & Mahboobi, N.
(2011). “Epidemiology and risk factors of HCV
infection among hemodialysis patients in countries of the
Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature”. Journal of Public Health,
Vol.19(2), pp.191-203.doi 10.1007/s10389-010-0366-2.
[3]. Asad, M., Zafar, H., Bukhari, K. T., & Yasir, I. (2013).
“Frequency of hepatitis B & C viral infections
amongst students of a medical school of islamabad,
pakistan”. Asian Journal of Agricultural and Biology,
Vol.1(4), pp.183-186.
[4]. Ali, S. A., Donahue, R. M., Qureshi, H., & Vermund, S. H.
(2009). “Hepatitis B and hepatitis C in Pakistan: prevalence
and risk factors”. International Journal of Infectious
Diseases, Vol.13(1), pp.9-19. doi:10.1016/j.ijid.2008.06.
019.
[5]. Awofeso, N. (2010). “Prisons as social determinants of
hepatitis C virus and tuberculosis infections”. Public Health
Reports, Vol.125(Suppl 4), pp.25-33.
[6]. Baha, W., Foullous, A., Dersi, N., They-they, T. P.,
Nourichafi, N., Oukkache, B., & Bennani, A. (2013).
“Prevalence and risk factors of hepatitis B and C virus
infections among the general population and blood
donors in Morocco”. BMC Public Health, Vol.13(1), pp.1-
8.doi:10.1186/1471-2458-13-50.
[7]. Drainoni, M. L., Litwin, A. H., Smith, B. D., Koppelman, E.
A., McKee, M. D., Christiansen, C. L., ... & Southern, W. N.
(2012). “Effectiveness of a risk screener in identifying
hepatitis C virus in a primary care setting”. American
Journal of Public Health, Vol.102(11), pp.115-121.
[8]. European Paediatric Hepatitis C Virus Network. 2005.
“A significant sex—But not elective caesarean
section-effect on mother-to-child transmission of hepatitis
C virus infection”. J Infect Dis, Vol. 192, pp.1872– 1879.
[9]. Frimpong, J. A., D'Aunno, T., & Jiang, L. (2014).
“Determinants of the Availability of Hepatitis C Testing
Services in Opioid Treatment Programs: Results From a
National Study”. American Journal of Public Health,
Vol.104(6), pp.75-82.doi:10.2105/AJPH.2013.301827.
[10]. Ghias, M., & Pervaiz, M. K. (2009). “Identification of
epidemiological risk factors for hepatitis c in Punjab,
Pakistan”. J Ayub Med Coll Abbottabad, Vol.21(2), pp.156-
161. Retrieved from: http://www.ayubmed. edu.pk/JAMC/
PAST/156 21-2/Ghias.pdf
[11]. Hyder, O., Ijaz, M., Arshad, M. A., & Zahira, T. (2010). “Age-specific frequency of scren-detected hepatitis C virus
seropositivity in men from the Punjab province of Pakistan”.
Journal of Medical Screening, Vol.17(4), pp.214-216.
doi:10.1258/jms.2010.010101
[12]. Indolfi, G., & Resti, M. (2009). “Perinatal transmission of
hepatitis C virus infection”. Journal of Medical
Virology, Vol.81(5), pp.836-843.doi 10.1002/jmv.21316.
[13]. Janjua, N. Z., & Nizamy, M. A. M. (2006). “Knowledge
and practices of barbers about hepatitis B and C
transmission in Rawalpindi and Islamabad”. Journal-
Pakistan Medical Association, Vol.54(3), pp.116-118.
[14]. Khan, M. I., Zhaidi, A. A., Mehar, A., Ahmed, R.,
Zahoor, S., Sarfaraz, A., & Safdar, M. S. (2012). “Assessment
of knowledge and practice of barbers & beauticians
regarding hepatitis B and C. Gomal”. Journal of Medical
Sciences, Vol.10(1), pp.127-132.
[15]. Kuo, I., Galai, N., Thomas, D. L., & Zafar, T. (2006).
“High HCV seroprevalence and HIV drug use risk behaviors
among injection drug users in Pakistan”. Harm Reduction
Journal, Vol.3(26), pp.1-10. doi:10.1186/1477-7517-3-26.
[16]. Lim, Y. S., & Kim, W. (2008). “The global impact of
hepatic fibrosis and end-stage liver disease”. Clinics in Liver
Disease, Vol.12(4), pp.733-746. doi: 10.1016/j.cld.
2008.07.007.
[17]. Mitchell, A. E., Colvin, H. M., & Palmer Beasley, R.
(2010). “Institute of Medicine recommendations for the
prevention and control of hepatitis B and C”. Hepatology,
Vol.51(3), pp.729-733.
[18]. Porter, J. C., Lusk, H. M., & Katz, A. R. (2014).
“Prevalence of HCV Infection Among Clients in Community
-Based Health Settings in Hawaii, 2002 - 2010 : Assessing
Risk Factors”. American Journal of Public Health, Vol.104(8),
pp.1534-1539. doi:10.2105/AJPH. 2013.301282.
[19]. Removille, N., Origer, A., Couffignal, S., Vaillant, M.,
Schmit, J. C., & Lair, M. L. (2013). “A hepatitis A, B, C and HIV
prevalence and risk factor study in ever injecting and noninjecting
drug users in Luxembourg associated with HAV
and HBV immunisations”. BMC Public Health, Vol.11(1),
pp.382-385. doi: 10.5812/hepatmon.5940.
[20]. Saleem, M., Ahmad, W., Sarwar, J., Jamshed, F., Gul, N., & Idrees, M. (2011). “Frequency of hepatitis C in asymptomatic patients in district headquarters hospital
Kotli, Azad Kashmir”. J Ayub Med Coll Abbottabad,
Vol.23(2), pp.59-62.
[21]. Din, H., Siddiqui, T. S., Lahrasab, W., & Sharif, M. A.
(2012). “Prevalence of hepatitis B and C in healthy adult
males of paramilitary personnel in Punjab”. Journal of Ayub
Medical College, Abbottabad: JAMC, Vol.24(3-4), pp.138-
140.
[22]. Smith, B. D., Beckett, G. A., Yartel, A., Holtzman, D.,
Patel, N., & Ward, J. W. (2014). “Previous Exposure to HCV
Among Persons Born During 1945–1965: Prevalence and
Predictors, United States, 1999–2008”. American Journal of
Public Health, Vol.104(3), pp.474-481. doi:10.2105/AJPH.
2013.301549.
[23]. Tohme, R. A., Xing, J., Liao, Y., & Holmberg, S. D.
(2013). “Hepatitis C testing, infection, and linkage to care
among racial and ethnic minorities in the United States,
2009–2010”. American Journal of Public Health,
Vol.103(1), pp.112-119.doi:10.2105/AJPH.2012.300858.
[24]. Waheed, Y., Shafi, T., Safi, S. Z., & Qadri, I. (2009).
“Hepatitis C virus in Pakistan: a systematic review of
prevalence, genotypes and risk factors”. World Journal of
Gastroenterology: WJG, Vol.15(45),pp.5647-5653.doi:10.3748/ wjg.15.5647.
[25]. Wenger, P. J., Rottnek, F., Parker, T., & Crippin, J. S. (2014). “Assessment of Hepatitis C Risk Factors and
Infection Prevalence in a Jail Population”. American
Journal of Public Health, Vol.104(9), pp.1722-1727.doi:
10.2105/AJPH.2014. 301996.
[26]. World Health Organization (2014). “Hepatitis C Fact
Sheet”. Geneva: WHO; 2014. Retrieved on 24, September,
2014from: http://www.who.int/mediacentre/factsheets/fs164/en/
[27]. Yahya, K. M., Khan, R. R., Aziz, U., & Hussain, S. A.
(2013). “Frequency of various Hepatitis C Virus (HCV)
genotypes in faisalabad and surrounding districts”, Journal
University Medical and Dental College (JUMDC), Vol.4(2),
pp.57-62.
[28]. Younus, M., Siddiqi, A. E. A., & Akhtar, S. (2009).
“Reassessment of selected healthcare associated risk
factors for HBV and HCV infections among volunteer blood
donors, Karachi, Pakistan”. Central European Journal of
Public Health, Vol.17(1), pp.31-35.
[29]. Zibbell, J. E., Hart-Malloy, R., Barry, J., Fan, L., &
Flanigan, C. (2014). “Risk Factors for HCV Infection Among
Young Adults in Rural New York Who Inject Prescription
Opioid Analgesics”. American Journal of Public Health,
Vol.104(11),pp.2226-2232.doi:10.2105/AJPH.2014.302142.